Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration (FDA) held in December 2024. The meeting ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single ...

The U.S. food supply is generally considered safe, but tens of millions of people get sick from foodborne illnesses each year ...

Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...

The U.S. Food and Drug Administration (FDA) this week set maximum levels for lead in baby foods such as jarred fruits and ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

The Food and Drug Administration have seen a number of food items pulled from the shelves since the start of 2025, with the ...

Protein powders may contain high levels of lead and cadmium, with chocolate-flavored and plant-based products testing at the ...